We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Microfluidic Systems for Biomarker Analysis and Cancer Diagnosis

Video   May 12, 2014

 

About the Speaker


Martin A. M. Gijs is a professor in the Institute of Microengineering, where he is responsible for the Microsystems Technology Group. His main interests are in developing technologies for novel magnetic devices, new microfabrication technologies for microsystems fabrication in general and the development and use of microfluidics for biomedical applications in particular. AbstractWe first report on a magnetic surface coverage assay, in which ‘large’ (2.8 µm) magnetic beads have contact with ‘small’ (1.0 µm) immobilized magnetic beads via magnetic dipolar interaction to induce specific immunocomplex formation. This attractive magnetic force is carefully balanced with a viscous drag imposed by a microfluidic flow to remove non-specifically bound large magnetic beads. In this way, a fg mL-1 limit of detection was demonstrated for Tumor Necrosis Factor-alpha (TNF-alpha) in serum, by counting of the number of surface-bound large beads. Subsequently, we report a microfluidic tissue processor that permits accurate quantification of the expression of biomarkers on tissue sections, as enabled by the ultra-rapid and uniform fluidic exchange of the device. An important clinical biomarker for invasive breast cancer is the human epidermal growth factor receptor 2 (HER2). Using our device, we performed tests on invasive breast carcinoma cases expressing various levels of HER2 and demonstrated the clinical potential of microfluidics for accurate biomarker expression analysis. 

 
 
 
 

Recommended Videos

What is Leukemia?

Video

Stem cells found in the bone marrow are crucial for our health because they are needed to become new blood cells that sustain and protect our bodies. But when the transformation goes wrong, harmful mutations can cause the cells to start replicating without control -- a type of cancer known as leukemia.

WATCH NOW

Genetic Causes of Myeloma

Video

Myeloma occurs as a result of changes in the genetic material within plasma cells. This animation explains what happens at the genetic level which causes myeloma to develop.

WATCH NOW

Cancer Cell Biology: Mutated KRAS & Reciprocal Signaling

Video

Across a wide variety of cancer types, a protein called KRAS can get hyperactivated and transmit an overload of unwanted growth signals to the cells, causing them to divide and form a tumor.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Cancer Research Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE